ZEMAX renewal of DBP licenses.

The contract involves the renewal of DBP licenses for ZEMAX, a software used for optical design. This renewal is being managed by the Food and Drug Administration (FDA) and falls under the NAICS code 511210, which pertains to software publishers. The contract is currently in the forecast stage as of March 11, 2026, indicating that it is planned but not yet finalized. Specific details about the place of performance, set-aside status, and the contracting officer are not provided at this time. Points of contact include the CDRH Acquisition Liaison, reachable via a designated FDA email, and a contracting officer who has yet to be determined. The opportunity is listed on the FDA’s industry forecast platform, which serves to inform potential vendors about upcoming contract opportunities. This renewal is critical for maintaining software licenses essential for the FDA’s optical design and analysis capabilities.